You searched for "forceps"

809 results found

It’s not always GCA

Giant cell arteritis (GCA) is an immune mediated granulomatous inflammatory disease that affects muscular middle or large sized arteries. It is considered as a continuation of polymyalgia rheumatica (PMR) when the severity of the disease has increased. It is the...

Useful, interesting, or maybe both

This column is often, but not always, about ophthalmic tech. This is one of those ‘not always’ editions. Time to share some interesting or useful things from the internet which can help in a number of ways, from preparing presentations...

Certifying patients as visually impaired: the start of a journey

In March 2017 there were 290,475 people registered as either visually impaired or severely visually impaired in the UK [1]. Patients registered as sight impaired benefit from financial support as well as practical help. Practical help is provided by social...

Ophthalmology Foundation: a promising new beginning

The world’s leaders in ophthalmology have created the new Ophthalmology Foundation, to make prevention of blindness and maintenance of high quality vision accessible to people of all nations. Board of Directors President David EI Pyott explains their vision for the...

When science meets art: Creating brilliant sparks

I was honoured to have the privilege of reconnecting with the Tongren Eye Center team in Beijing, China. Digital art in mainstream media has showcased some glorious works and it is humbling to see and hear about some creative new...

Genetic profiling for personalised healthcare solutions in AMD – an update

Age-related macular degeneration (AMD) is a multifactorial condition influenced by genetics and lifestyle factors (Table 1). This article outlines several recent advances in AMD genetics, as well as evolving therapeutic concepts and established practical measures for the treatment and /...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

‘Agenda-setting’ BCLA Clinical Conference to shape the future of contact lens practice around the world

The global eye care professional network’s “unquenchable thirst for learning” ensured the success of the first in-person BCLA Clinical Conference & Exhibition in four years.

OSA Insights to Market win praise from members

OSA members praised the breadth of optical market insights provided by the Autumn meeting this week as a broad spectrum of suppliers gathered in London, reinforcing the strength of the trade body.

Traffic Lights

For this issue’s instalment of The Culture Section, I was privileged to speak to Moorfield’s first prize competition winner Charlotte Zheng. Earlier this year in January, Charlotte wrote a patient reflection poem for the prize competition titled ‘Patient as Teacher...

Dissecting the green credentials of ophthalmology virtual clinics

Since 2006, the NHS’ long-term plans have consistently advocated and resourced telemedicine. The current 10-year plan that was announced in 2019 aimed to cut face-to-face outpatient visits by one-third by 2024, by adopting digital consultations. The NHS plan calculates that...

What's trending Oct/Nov 2026

A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #Solar #Eclipse Of course, there isn’t any other way I could possibly start this issue’s section. The recent solar eclipse, a...